Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Aditxt, Inc. ( (ADTX) ) has issued an announcement.
Aditxt, Inc. announced that its Board of Directors has authorized management to explore an initial public offering (IPO) for its subsidiary Pearsanta, Inc. in 2025, aiming to support the global launch of its early cancer detection platform. This move is intended to provide Pearsanta with the necessary resources to accelerate its growth and expand its market presence, enhancing the commercialization of its Mitomic® Technology for early cancer detection, which could empower clinicians with tools for earlier and more accurate diagnoses.
More about Aditxt, Inc.
Aditxt, Inc. is a social innovation platform focused on accelerating promising health innovations through a collaborative ecosystem involving research institutions, industry partners, and shareholders. Operating primarily in the health sector, Aditxt drives innovation across multiple disciplines to address significant societal challenges, with programs focused on immune health, precision health, public health, and women’s health.
YTD Price Performance: -15.50%
Average Trading Volume: 5,638,750
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.42M
For detailed information about ADTX stock, go to TipRanks’ Stock Analysis page.
